SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A decrease of about -41.68% in the sales to Rs. 4977.15 millions was observed for the quarter ended December 2023. The sales stood at Rs. 8534.04 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 367.95 millions from Rs. 1308.72 millions, a decline of -71.88% on QoQ basis.Operating Profit reported a sharp decline to 1143.80 millions from 2349.46 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 4977.15 8534.04 -41.68 14156.14 20204.99 -29.94 33127.33 29464.36 12.43
Other Income 987.24 736.89 33.97 2425.22 1262.55 92.09 1735.68 484.09 258.54
PBIDT 1143.80 2349.46 -51.32 1587.49 3283.83 -51.66 6632.36 6393.56 3.74
Interest 4.87 7.45 -34.63 52.64 16.88 211.85 38.69 16.27 137.80
PBDT 1138.93 2342.01 -51.37 1534.85 3266.95 -53.02 6593.67 6377.29 3.39
Depreciation 686.13 653.04 5.07 2128.34 1804.16 17.97 2480.65 2452.93 1.13
PBT 452.80 1688.97 -73.19 -593.49 1462.79 -140.57 4113.02 3924.36 4.81
TAX 84.85 380.25 -77.69 -135.16 324.32 -141.67 865.59 1095.45 -20.98
Deferred Tax 87.65 190.32 -53.95 -132.36 134.39 -198.49 145.52 359.15 -59.48
PAT 367.95 1308.72 -71.88 -458.33 1138.47 -140.26 3247.43 2828.91 14.79
Equity 902.20 902.20 0.00 902.21 902.21 0.00 902.20 902.20 0.00
PBIDTM(%) 22.98 27.53 -16.53 11.21 16.25 -31.00 20.02 21.70 -7.74

Sharda Cropchem Share Price

1057.70 23.90 (2.31%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
UPL 644.80
PI Industries 2952.55
Bayer CropScience 4794.65
Sharda Cropchem 1057.70
Sumitomo Chemical 418.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×